Novel small-molecule inhibitors of arylamine N-acetyltransferases: drug discovery by high-throughput screening.
Arylamine N-acetyltransferases (NATs) are a family of enzymes found in eukaryotes and prokaryotes. While the precise endogenous function of NAT remains unknown for most organisms, recent evidence has shown that the expression of human NAT1 is up-regulated in estrogen receptor positive breast cancer....
主要な著者: | Westwood, I, Kawamura, A, Russell, A, Sandy, J, Davies, S, Sim, E |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2011
|
類似資料
-
Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2.
著者:: Russell, A, 等
出版事項: (2009) -
Structure and mechanism of arylamine N-acetyltransferases.
著者:: Westwood, I, 等
出版事項: (2006) -
Synthesis and in vitro evaluation of novel small molecule inhibitors of bacterial arylamine N-acetyltransferases (NATs).
著者:: Brooke, E, 等
出版事項: (2003) -
Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding
著者:: Laurieri, N, 等
出版事項: (2014) -
Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening.
著者:: Kawamura, A, 等
出版事項: (2005)